logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Lates News

date
10/11/2025
AstraZeneca: Baxdrostat demonstrates significant blood pressure reduction in phase III clinical trials, achieving primary endpoints.
Latest
2 m ago
Australia's Deputy Reserve Bank Governor Hofer: We will explore to determine the neutral interest rate and judge the degree of policy relaxation by evaluating the macroeconomic situation.
2 m ago
Summary of the Bank of Japan's October meeting: One member stated that if economic and price forecasts materialize, the Bank of Japan is expected to continue raising interest rates.
4 m ago
The Republican Party of the US Senate has put forward a temporary spending bill with an expiration date of January 30th.
4 m ago
New Stock News | True Biotech Thirds Submissions to Hong Kong Stock Exchange Core Product Azvudine Granted Conditional Approval for Treatment of HIV Infection and COVID-19 in China
6 m ago
The Senate Appropriations Committee has released a new interim measure bill text.
See all latestmore
logo
Contact US
qr
+852 - 60190728
[email protected]
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.